Ballentine Partners LLC boosted its holdings in shares of The Allstate Co. (NYSE:ALL - Free Report) by 32.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,940 shares of the insurance provider's stock after purchasing an additional 4,191 shares during the period. Ballentine Partners LLC's holdings in Allstate were worth $3,213,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in ALL. Northwest Investment Counselors LLC acquired a new position in Allstate in the 3rd quarter worth about $28,000. Versant Capital Management Inc lifted its position in shares of Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider's stock valued at $30,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. purchased a new position in shares of Allstate during the 2nd quarter valued at approximately $38,000. MCF Advisors LLC grew its stake in Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock valued at $53,000 after acquiring an additional 84 shares during the period. Finally, First Command Advisory Services Inc. purchased a new stake in Allstate in the 2nd quarter worth $58,000. 76.47% of the stock is owned by hedge funds and other institutional investors.
Allstate Trading Down 2.0 %
ALL traded down $3.88 during trading hours on Friday, reaching $188.12. The company's stock had a trading volume of 1,151,391 shares, compared to its average volume of 1,536,326. The stock has a market cap of $49.65 billion, a PE ratio of 41.53, a P/E/G ratio of 1.74 and a beta of 0.48. The Allstate Co. has a fifty-two week low of $122.53 and a fifty-two week high of $198.79. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. The business's 50-day moving average is $188.01 and its 200-day moving average is $174.36.
Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, beating the consensus estimate of $0.33 by $1.28. The business had revenue of $15.71 billion for the quarter, compared to analyst estimates of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The company's quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter in the prior year, the company posted ($4.42) EPS. As a group, equities research analysts predict that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
ALL has been the topic of several recent analyst reports. Roth Mkm reaffirmed a "buy" rating and set a $200.00 price objective on shares of Allstate in a report on Wednesday, August 14th. Evercore ISI raised their target price on Allstate from $191.00 to $195.00 and gave the company an "in-line" rating in a research report on Wednesday, October 9th. Bank of America boosted their price target on Allstate from $216.00 to $233.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Keefe, Bruyette & Woods raised their price objective on Allstate from $199.00 to $208.00 and gave the company an "outperform" rating in a report on Monday, August 12th. Finally, Barclays assumed coverage on shares of Allstate in a research note on Wednesday, September 4th. They set an "underweight" rating and a $175.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $206.44.
Get Our Latest Analysis on Allstate
Insider Activity at Allstate
In related news, CEO Thomas J. Wilson sold 90,000 shares of the company's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares of the company's stock, valued at $15,880,915.68. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Elizabeth Brady sold 49,481 shares of the business's stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is currently owned by company insiders.
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.